(Q39318382)

11 September 2017

Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease (English)

1 reference

Human T-lymphotropic virus 1

11 September 2017

0 references

author

Unsong Oh

1

1 reference

11 September 2017

6

1 reference

11 September 2017

2

Yoshihisa Yamano

1 reference

11 September 2017

Carlos A Mora

3

1 reference

11 September 2017

Joan Ohayon

4

1 reference

11 September 2017

Francesca Bagnato

5

1 reference

11 September 2017

James Dambrosia

7

1 reference

11 September 2017

Thomas P Leist

8

1 reference

11 September 2017

Henry McFarland

9

1 reference

11 September 2017

Steven Jacobson

10

1 reference

11 September 2017

1 April 2005

1 reference

11 September 2017

1 reference

11 September 2017

57

1 reference

11 September 2017

526-534

1 reference

11 September 2017

4

1 reference

HTLV-I uveitis: a distinct clinical entity caused by HTLV-I

11 September 2017

1 reference

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study

21 January 2018

1 reference

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

21 January 2018

1 reference

An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease

21 January 2018

1 reference

Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site

21 January 2018

1 reference

IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor alpha promoter

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.20429

1 reference

11 September 2017

1 reference